vs
Astrana Health, Inc.（ASTH）与FactSet（FDS）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是FactSet的1.6倍（$950.5M vs $607.6M），FactSet净利率更高（25.1% vs 0.7%，领先24.4%），Astrana Health, Inc.同比增速更快（42.9% vs 6.9%），FactSet自由现金流更多（$90.4M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 5.5%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
FactSet是总部位于美国康涅狄格州诺沃克的金融数据与软件企业，为客户提供一体化数据及软件解决方案。2024财年，公司年度订阅价值与专业服务营收合计22亿美元，当前总市值约170亿美元。
ASTH vs FDS — 直观对比
营收规模更大
ASTH
是对方的1.6倍
$607.6M
营收增速更快
ASTH
高出36.0%
6.9%
净利率更高
FDS
高出24.4%
0.7%
自由现金流更多
FDS
多$96.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
5.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $607.6M |
| 净利润 | $6.6M | $152.6M |
| 毛利率 | — | 52.6% |
| 营业利润率 | 1.9% | 31.6% |
| 净利率 | 0.7% | 25.1% |
| 营收同比 | 42.9% | 6.9% |
| 净利润同比 | 184.4% | 1.7% |
| 每股收益（稀释后） | $0.12 | $4.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFDS
| Q4 25 | $950.5M | $607.6M | ||
| Q3 25 | $956.0M | $596.9M | ||
| Q2 25 | $654.8M | $585.5M | ||
| Q1 25 | $620.4M | $570.7M | ||
| Q4 24 | $665.2M | $568.7M | ||
| Q3 24 | $478.7M | $562.2M | ||
| Q2 24 | $486.3M | $552.7M | ||
| Q1 24 | $404.4M | $545.9M |
净利润ASTHFDS
| Q4 25 | $6.6M | $152.6M | ||
| Q3 25 | $373.0K | $153.6M | ||
| Q2 25 | $9.4M | $148.5M | ||
| Q1 25 | $6.7M | $144.9M | ||
| Q4 24 | $-7.8M | $150.0M | ||
| Q3 24 | $16.1M | $89.5M | ||
| Q2 24 | $19.2M | $158.1M | ||
| Q1 24 | $14.8M | $140.9M |
毛利率ASTHFDS
| Q4 25 | — | 52.6% | ||
| Q3 25 | — | 51.6% | ||
| Q2 25 | — | 52.1% | ||
| Q1 25 | — | 52.8% | ||
| Q4 24 | — | 54.5% | ||
| Q3 24 | — | 54.1% | ||
| Q2 24 | — | 55.3% | ||
| Q1 24 | — | 53.3% |
营业利润率ASTHFDS
| Q4 25 | 1.9% | 31.6% | ||
| Q3 25 | 2.0% | 29.7% | ||
| Q2 25 | 3.1% | 33.2% | ||
| Q1 25 | 3.3% | 32.5% | ||
| Q4 24 | 0.1% | 33.6% | ||
| Q3 24 | 5.9% | 22.7% | ||
| Q2 24 | 6.2% | 36.6% | ||
| Q1 24 | 7.5% | 33.3% |
净利率ASTHFDS
| Q4 25 | 0.7% | 25.1% | ||
| Q3 25 | 0.0% | 25.7% | ||
| Q2 25 | 1.4% | 25.4% | ||
| Q1 25 | 1.1% | 25.4% | ||
| Q4 24 | -1.2% | 26.4% | ||
| Q3 24 | 3.4% | 15.9% | ||
| Q2 24 | 3.9% | 28.6% | ||
| Q1 24 | 3.7% | 25.8% |
每股收益（稀释后）ASTHFDS
| Q4 25 | $0.12 | $4.06 | ||
| Q3 25 | $0.01 | $4.03 | ||
| Q2 25 | $0.19 | $3.87 | ||
| Q1 25 | $0.14 | $3.76 | ||
| Q4 24 | $-0.14 | $3.89 | ||
| Q3 24 | $0.33 | $2.33 | ||
| Q2 24 | $0.40 | $4.09 | ||
| Q1 24 | $0.31 | $3.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $292.7M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $779.3M | $2.2B |
| 总资产 | $2.2B | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资ASTHFDS
| Q4 25 | $429.5M | $292.7M | ||
| Q3 25 | $463.4M | $355.1M | ||
| Q2 25 | $342.1M | $364.0M | ||
| Q1 25 | $260.9M | $287.0M | ||
| Q4 24 | $290.8M | $358.8M | ||
| Q3 24 | $350.3M | $492.6M | ||
| Q2 24 | $327.7M | $522.0M | ||
| Q1 24 | $337.3M | $450.2M |
总债务ASTHFDS
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.5B |
股东权益ASTHFDS
| Q4 25 | $779.3M | $2.2B | ||
| Q3 25 | $775.5M | $2.2B | ||
| Q2 25 | $765.5M | $2.2B | ||
| Q1 25 | $745.4M | $2.1B | ||
| Q4 24 | $712.7M | $2.0B | ||
| Q3 24 | $704.6M | $1.9B | ||
| Q2 24 | $678.9M | $1.9B | ||
| Q1 24 | $653.5M | $1.8B |
总资产ASTHFDS
| Q4 25 | $2.2B | $4.2B | ||
| Q3 25 | $2.2B | $4.3B | ||
| Q2 25 | $1.4B | $4.3B | ||
| Q1 25 | $1.3B | $4.2B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | $1.3B | $4.1B | ||
| Q2 24 | $1.3B | $4.0B | ||
| Q1 24 | $1.2B | $4.0B |
负债/权益比ASTHFDS
| Q4 25 | — | 0.63× | ||
| Q3 25 | — | 0.63× | ||
| Q2 25 | — | 0.66× | ||
| Q1 25 | — | 0.72× | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $121.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $90.4M |
| 自由现金流率自由现金流/营收 | -0.6% | 14.9% |
| 资本支出强度资本支出/营收 | 0.3% | 5.1% |
| 现金转化率经营现金流/净利润 | -0.44× | 0.79× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $647.4M |
8季度趋势，按日历期对齐
经营现金流ASTHFDS
| Q4 25 | $-2.9M | $121.3M | ||
| Q3 25 | $10.0M | $212.1M | ||
| Q2 25 | $90.9M | $253.8M | ||
| Q1 25 | $16.6M | $174.0M | ||
| Q4 24 | $-10.9M | $86.4M | ||
| Q3 24 | $34.0M | $163.2M | ||
| Q2 24 | $23.2M | $238.2M | ||
| Q1 24 | $6.0M | $143.8M |
自由现金流ASTHFDS
| Q4 25 | $-6.0M | $90.4M | ||
| Q3 25 | $7.4M | $178.1M | ||
| Q2 25 | $89.5M | $228.6M | ||
| Q1 25 | $13.6M | $150.2M | ||
| Q4 24 | $-13.5M | $60.5M | ||
| Q3 24 | $31.7M | $137.2M | ||
| Q2 24 | $20.4M | $216.9M | ||
| Q1 24 | $5.6M | $121.9M |
自由现金流率ASTHFDS
| Q4 25 | -0.6% | 14.9% | ||
| Q3 25 | 0.8% | 29.8% | ||
| Q2 25 | 13.7% | 39.0% | ||
| Q1 25 | 2.2% | 26.3% | ||
| Q4 24 | -2.0% | 10.6% | ||
| Q3 24 | 6.6% | 24.4% | ||
| Q2 24 | 4.2% | 39.2% | ||
| Q1 24 | 1.4% | 22.3% |
资本支出强度ASTHFDS
| Q4 25 | 0.3% | 5.1% | ||
| Q3 25 | 0.3% | 5.7% | ||
| Q2 25 | 0.2% | 4.3% | ||
| Q1 25 | 0.5% | 4.2% | ||
| Q4 24 | 0.4% | 4.5% | ||
| Q3 24 | 0.5% | 4.6% | ||
| Q2 24 | 0.6% | 3.9% | ||
| Q1 24 | 0.1% | 4.0% |
现金转化率ASTHFDS
| Q4 25 | -0.44× | 0.79× | ||
| Q3 25 | 26.69× | 1.38× | ||
| Q2 25 | 9.65× | 1.71× | ||
| Q1 25 | 2.48× | 1.20× | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | 2.11× | 1.82× | ||
| Q2 24 | 1.21× | 1.51× | ||
| Q1 24 | 0.40× | 1.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FDS
| Americas Segment | $399.7M | 66% |
| EMEA Segment | $149.1M | 25% |
| Asia Pacific Segment | $62.2M | 10% |
